Bluetongue virus serotype 3 in ruminants in the Netherlands: Clinical signs, seroprevalence and pathological findings
Veterinary Record · 17.08.2024 · 195 (4)
DOI: 10.1002/vetr.4533 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Record, online erschienen am 15.08.2024. Verfasst von Katrien M J A van den Brink und 12 weiteren Autor:innen. Beteiligte Einrichtung: Royal GD, Deventer, The Netherlands. Hauptthemen laut MEDLINE: Bluetongue virus, Bluetongue, Disease Outbreaks, Serogroup. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Agriculture, Nature and Food Quality (LNV).
Abstract (Originalsprache)
Background
The bluetongue virus serotype 3 (BTV‐3) outbreak in the Netherlands in 2023 caused severe clinical signs in ruminants. The clinical and pathological signs in ruminants and their spread during the outbreak in 2023 are described.
Methods
Data from the Dutch monitoring and surveillance system were available to describe clinical signs and pathological findings related to BTV‐3 in sheep, cattle and goats. During the outbreak, 13 farms (five sheep, five cattle and three dairy goats) were closely monitored.
Results
In 2023, BTV‐3 infections were confirmed by real‐time polymerase chain reaction in sheep flocks ( n = 1807), cattle herds ( n = 1864), goat herds ( n = 62), alpaca and/or llama herds ( n = 15) and one dog. Sheep exhibited the most severe clinical signs and had the highest mortality. In other animal species, a large variation in both occurrence and severity of clinical signs was observed. Limitation Only 13 farms were closely monitored.
Conclusions
The clinical signs observed in affected animals during the 2023 BTV‐3 outbreak seem to be more severe than those observed during the BTV‐8 outbreak between 2006 and 2008. It seems likely that BTV‐3 will overwinter, similar to BTV‐8. Therefore, the availability of an effective and safe vaccine is crucial to limit the future impact of BTV‐3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Royal GD, Deventer, The Netherlands.
- Wageningen Bioveterinary Research, Lelystad, The Netherlands.
- Dutch Food and Consumer Product Safety Authority (NVWA), Utrecht, The Netherlands.
ORCID-Profile: Katrien M J A van den Brink, Eveline Dijkstra
Förderung
- Ministry of Agriculture, Nature and Food Quality (LNV)
Zitieren
APA
van den Brink, K. M. J. A., Santman-Berends, I. M. G. A., Harkema, L., Scherpenzeel, C. G. M., Dijkstra, E., Bisschop, P. I. H., Peterson, K., van de Burgwal, N. S., Waldeck, H. W. F., Dijkstra, T., Holwerda, M., Spierenburg, M. A. H., & van den Brom, R. (2024). Bluetongue virus serotype 3 in ruminants in the Netherlands: Clinical signs, seroprevalence and pathological findings. Veterinary Record, 195(4). https://doi.org/10.1002/vetr.4533
Vancouver
van den Brink KMJA, Santman-Berends IMGA, Harkema L, Scherpenzeel CGM, Dijkstra E, Bisschop PIH, et al. Bluetongue virus serotype 3 in ruminants in the Netherlands: Clinical signs, seroprevalence and pathological findings. Veterinary Record. 2024;195(4). doi:10.1002/vetr.4533
BibTeX
@article{vandenBrink2024,
author = {van den Brink, Katrien M J A and Santman-Berends, Inge M G A and Harkema, Liesbeth and Scherpenzeel, Christian G M and Dijkstra, Eveline and Bisschop, Petra I H and Peterson, Karianne and van de Burgwal, Nienke Snijders and Waldeck, Hubert W F and Dijkstra, Thomas and Holwerda, Melle and Spierenburg, Marcel A H and van den Brom, René},
title = {Bluetongue virus serotype 3 in ruminants in the Netherlands: Clinical signs, seroprevalence and pathological findings},
journal = {Veterinary Record},
year = {2024},
volume = {195},
number = {4},
doi = {10.1002/vetr.4533}
}
EUVIMED